Completed PHASE4 INTERVENTIONAL 2-arm NCT00978757

The Effect of Ketamine on Interleukin-6 Synthesis in Hepatic Resections Requiring Temporary Porto-arterial Occlusion

Phase 4: Study of Ketamine Inhibition of Interleukin 6 in Hepatic Resections Requiring Temporary Porto-arterial Occlusion

Sponsor: Hospital Italiano de Buenos Aires

Conditions Hepatectomy

Interventions Ketamine Placebo

Updated 8 times since 2017 Last updated: Dec 21, 2018 Started: Jun 30, 2001 Primary completion: Jun 30, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hepatectomy, this trial is completed. The trial is conducted by Hospital Italiano de Buenos Aires and has accumulated 8 data snapshots since 2001. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Feb 2019 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jul 2018 — Feb 2019 [monthly]

Completed PHASE4
Jun 2018 — Jul 2018 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Italiano de Buenos Aires

Data source: Hospital Italiano de Buenos Aires

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Buenos Aires, Argentina